Due Diligence Best Practices from Pharma Leaders

Through due diligence, investors and pharma companies take a closer look at their potential partner, the asset, and the deal itself to validate claims and evaluate risks. With many millions of dollars riding on the success of licensing and acquisition activities, a deal gone wrong can mean significant debt and wasted resources.

This eBook gathers best practices from top pharma companies and offers actionable steps for improving due diligence at life science companies of all sizes.


Please complete the form below

All fields marked with a * are required.

Create a structured evaluation process

There are a lot of moving parts involved in due diligence, a well-defined process and structure play a critical role in maintaining efficiency and impact. An effective way to structure the due diligence process, as explained in this Inova webinar, is to use themes and subthemes for each functional area to guide their experts.

Each theme is rated against an internal standard. For example, if the partner says the asset is Phase II ready, the experts will evaluate whether it fits their company’s standard for a Phase II ready asset.

Evaluation of Data Package Content and Quality

Significant Strength

Significantly exceeds internal standard

Better internal criteria: a potential benchmark

Moderate Strength

Exceeds internal standard

Somewhat better than internal criteria


Meets internal standard

Consistent with internal criteria

Moderate Gap

Below internal standard

Somewhat below internal criteria

Significant Gap

Significantly below internal standard

Markedly below internal criteria

Kick off the due diligence together
Filter & prioritize information requests
Document the history of your diligence
Preview eBook

8 Best Practices from Top Pharma companies

  • Kick off the due diligence together.

  • Filter & prioritize information requests.
  • Document the history of your diligence.

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 160 life science companies, including 60% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.